Position
Chief Financial Officer
Company
ADMA Biologics
RamseyManufacturingBiotechnologyHealth CareBiopharmaDescription
ADMA Biologics announces the transition of Brian Lenz from Executive Vice President, Chief Financial Officer & General Manager, ADMA BioCenters to a consulting role, effective April 1, 2024. Adam Grossman is appointed as Interim Chief Financial Officer and the company has initiated an executive search for a full-time replacement Chief Financial Officer.
Quick answer
ADMA Biologics Announces Executive Leadership Changes (February 28, 2024). ADMA Biologics is based in Ramsey, New Jersey, United States.
- What did ADMA Biologics announce on February 28, 2024?
- ADMA Biologics announces the transition of Brian Lenz from Executive Vice President, Chief Financial Officer & General Manager, ADMA BioCenters to a consulting role, effective April 1, 2024. Adam Grossman is appointed as Interim Chief Financial Officer and the company has initiated an executive search for a full-time replacement Chief Financial Officer.
- What does ADMA Biologics do?
- ADMA Biologics, Inc. is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics for the treatment of immunodeficient patients at risk for infection and...
- Where is ADMA Biologics based?
- ADMA Biologics is based in Ramsey, New Jersey, United States.
- Which similar companies made leadership changes around the same time?
- Jazz Pharmaceuticals plc (February 21, 2024), AbbVie Inc. (February 20, 2024), YS Biopharma (February 14, 2024) and Everest Medicines (March 18, 2024) also announced leadership changes within 45 days of ADMA Biologics.
Source: Fundz verified event record.
Other recent leadership changes in Biopharma and Manufacturing
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer (February 21, 2024)
- AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer (February 20, 2024)
- YS Biopharma Announces Appointment of New Directors (February 14, 2024)
- Everest Medicines Appoints Sandra Zeng as Chief Medical Officer and Rico Liang as Chief Product Officer (March 18, 2024)
- Bexion Pharmaceuticals Appoints Tariq Arshad as Chief Medical Officer (February 28, 2024)
- Corbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer (February 28, 2024)
Who to call at ADMA Biologics, and when
A new leader at ADMA Biologics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day ADMA Biologics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ADMA Biologics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ADMA Biologics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ADMA Biologics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ADMA Biologics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.